I. Erill a, S. Campoy b, N. Erill c, J. Barbé b, J. Aguiló a
a Biomedical Applications Group, Centro Nacional de Microelectrónica (CNN.IMB); b Departament de Genètica i Microbiologia / Centre de Recerca en Sanitat Animal (CReSA) Universitat Autònoma de Barcelona; c BIOPAT. Biopatología molecular. Grup Assistència.
Román R1, Colomer A1, Erill N1, Calvo M3, Verdú M2, Cordon-Cardo C4, Puig X1,2.
1BIOPAT, 2HISTOPAT Laboratoris and 3Statistics Dept. of the Universitat de Barcelona, Spain; and 4Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.
Human papillomavirus (HPV) is the main etiologic factor for cervical cancer and its types are classified into low and high oncogenic risk according to their capability of inducing invasive tumors. We studied 978 paraffin-embedded anogenital biopsies (730 cervical plus 248 extracervical) for the presence of […]
Erill N1, Colomer A1, Calvo M3, Vidal A2, Román R 1, Verdú M2, Cordon-Cardo C4, Puig X 1,2.
1BIOPAT, 2HISTOPAT Laboratoris, 3Statistics Dept. of the Universitat de Barcelona, Spain; and 4Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.
Chromosome 18q allelic loss (c18q LOH) seems to have prognostic significance in stage II colorectal carcinoma. In our laboratory c18q LOH was prospectively analyzed in a series of primary colorectal tumors using five markers (D18S55/58/61/64 and 69). Results of 207 PCR-based assays […]
Anna Colomer,1 Nadina Erill,1 Montse Verdú,2 Ruth Roman,1 August Vidal,1,2 Carlos Cordon-Cardo,1,3 Xavier Puig1,2
1BIOPAT, Grup Assistència, Barcelona; 2HISTOPAT Laboratoris, Barcelona; and 3Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.
Multiple studies using primary tumors have reported that alterations in p53 expression and detection of TP53 mutations are associated with clinical aggressiveness and poor response to specific therapies. However, there is no general agreement regarding the optimal technical approach to the analysis of p53. We have studied a series of […]
N. Hannaoui, N. Erill*, A. Colomer*, E. Vicente, A. Peña, E. Gómez, M. Verdú*, R. Román*, X. Puig*, JM. Banús
Institut Català d’Urologia i Nefrologia. * BIOPAT. Biopatologia molecular, S.L. Grup Assistència.